April 27 | 2023

Kallelse till årsstämma i 2cureX AB (publ)

Read more
April 27 | 2023

Notice of annual general meeting of 2cureX AB (publ)

Read more
April 25 | 2023

2cureX’s CEO Fernando Andreu purchases shares in the company

Read more
April 20 | 2023

2cureX offentliggör årsredovisning för räkenskapsåret 2022

Read more
April 20 | 2023

2cureX publishes the annual report for the fiscal year 2022

Read more
April 12 | 2023

2cureX has received a grant from the Innovation Fund Denmark to support clinical development of a novel IndiTreat® product.

Read more
April 6 | 2023

2cureX strengthens its IndiTreat® automation project with a prestigious grant from the German Federal Ministry of Education and Research

Read more
February 23 | 2023

2cureX publishes interim report for the fourth quarter and full year of 2022

Read more
February 15 | 2023

Invitation to 2cureX webcast on Year-End Report and latest news on February 24, 2023

Read more
February 10 | 2023

Announcement from extraordinary general meeting 2cureX AB

Read more
February 10 | 2023

Kommuniké från extra bolagsstämma i 2cureX AB

Read more
January 23 | 2023

NOTICE TO ATTEND THE EXTRAORDINARY GENERAL MEETING OF 2CUREX AB (PUBL)

Read more
January 23 | 2023

KALLELSE TILL EXTRA BOLAGSSTÄMMA I 2CUREX AB (PUBL)

Read more
January 19 | 2023

2cureX announces final results regarding 2022 goals

Read more
November 24 | 2022

2cureX publishes interim report for the third quarter and first nine months of 2022

Read more
November 14 | 2022

2cureX discloses status of 2022 plans, goals for 2023 and its estimates of potential market development in the coming years

Read more
September 29 | 2022

2cureX terminates liquidity provision service

Read more
August 25 | 2022

2cureX publishes interim report for the second quarter and first half of 2022

Read more